Phase 3, Randomized, Double-blind, Placebo/Active-controlled, Parallel-arm Trial to Assess Efficacy, Safety, and Pharmacokinetics of Dasiglucagon Relative to Placebo/GlucaGen as Rescue Therapy for Severe Hypoglycemia in Children With T1DM Treated With Insulin
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2019
At a glance
- Drugs Dasiglucagon
- Indications Hypoglycaemia
- Focus Registrational; Therapeutic Use
- Sponsors Zealand Pharma
- 04 Feb 2019 New source identified and integrated European Clinical Trials Database EudraCT2018-000892-33
- 15 Nov 2018 According to a Zealand Pharma media release, data readout from the trial is expected in 1H 2019.
- 27 Sep 2018 Status changed from not yet recruiting to recruiting, according to a Zealand Pharma media release.